We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Canine Blood Biomarkers Indicate Septic Infection in Humans Too

By LabMedica International staff writers
Posted on 22 Dec 2011
The amount of certain blood biomarkers is a good indication of infection in dogs, and the same would hold true in humans suffering from similar conditions. More...


In pets and people, the time it takes to diagnose an infection may mean life or death, and identifying ways to diagnose pet infections in approximately a third of the current diagnosis time could be used eventually for humans.

Veterinarians at the University of Missouri (Columbia, MO, USA) tested several biomarkers for infection in dogs. They found that found that measuring the amount of the blood biomarker N-terminal portion of pro C-type natriuretic peptide (NT-pCNP) is a good indication of infection, and the same could be applied in humans. In one study, the NT-pCNP assay was performed by a sandwich enzyme-linked immunoassay (ELISA), (Biomedica Medizinprodukte GmbH & Co KG, Vienna, Austria). This ELISA utilizes a highly purified polyclonal sheep antibody directed against amino acids 1-19 and 30-50 of human NT-pCNP that is 96% homologous with canine pCNP.

In a separate study plasma samples obtained from both septic and normal control groups were used for determination of the nitric oxide end products nitrate (NO3–) and nitrite (NO2–) using a commercially available kit , the Parameter Total Nitric Oxide and Nitrite/Nitrate Assay; (R&D Systems, Minneapolis, MN, USA). This two-step assay utilizes nitrate reductase to convert nitrate to nitrite and then detects total nitrite using the Greiss reaction to produce an azo dye compound. The range of detection of this assay is 3.12-200 µmol/L.

Plasma total nitrate/nitrite was significantly greater in the sepsis group compared with the control group and a systemic inflammatory response syndrome (SIRS) group. Serum NT-pCNP concentration was significantly greater in the sepsis group (median, 11 pmol/L) compared with the noninfectious forms of SIRS (5.2 pmol/L); and healthy control groups (6.4 pmol/L). Amy DeClue, DVM, assistant professor of veterinary internal medicine, said, "My group has been evaluating different blood biomarkers that could give a quick and accurate indication of infection, and we believe we've found a biomarker that will only require a simple blood test. The systems in dogs and people are very applicable to each other, so whatever biomarkers we find in dogs could also benefit people."

The scientists hope to develop a portable bedside test that veterinarians could use to quickly test patients for infection and ultimately target a better cure. The NT-pCNP biomarker study was published in the May/June 2011 issue of Journal of Veterinary Internal Medicine and the plasma nitrate/nitrite study was published online on September 9, 2011, in the journal Veterinary Record.

Related Links:
University of Missouri
Biomedica Medizinprodukte
R&D Systems



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
New
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Microbiology

view channel
Image: The groundbreaking salmonella antimicrobial resistance prediction platform has demonstrated 95% accuracy (Photo courtesy of Yujie You et al., DOI: 10.1016/j.eng.2025.01.013)

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. Accurate prediction of resistance is crucial for effective... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.